Harry Alcorn, Jr.

Overview

Harry Alcorn, Jr. received an average of $611K in total compensation, including $289K in salary, at DiaMedica Therapeutics from 2019 to 2021.

Source: SEC filings on April 5, 2022 and April 20, 2020.

Related executives

We found five more executives who work or worked at DiaMedica Therapeutics.

Rick Pauls

DiaMedica Therapeutics

Chief Executive Officer

Scott Kellen

DiaMedica Therapeutics

Chief Financial Officer

Kirsten Gruis

DiaMedica Therapeutics

Chief Medical Officer

Julie Daves

DiaMedica Therapeutics

SVP, Clinical Development Operations

Todd Verdoorn

DiaMedica Therapeutics

Chief Scientific Officer

News

You may also like